Value of DSC in characterization and optimization of protein stability as compared to other thermal stability assays

Similar documents
Use of ITC/DSC for the studies of biomolecularstability and interaction of excipients with proteins. Natalia Markova

Regulatory Consideration for the Characterization of HOS in Biotechnology Products

nanodsf 2bind: Your service provider for biophysical characterization of proteins Precisely revealing protein folding and stability

Zetasizer ZS Helix (DLS/Raman) For Characterization of Pharmaceuticals and Biopharmaceuticals

High-throughput Biophysical Analysis of Protein Stability: Comparability Assessments and Formulation Development

ARBRE-P4EU Consensus Protein Quality Guidelines for Biophysical and Biochemical Studies Minimal information to provide

Degradation of Biological Products and Impact on Higher Order Structure

Stability of sub-unit vaccines measured with the UNit label-free stability platform

Challenges in Optimizing Formulations for Multi- Antigen Vaccines

Prometheus Series Product Information

Formulation Optimization Using the HUNK

Best Practices in Formulation and Lyophilization Development Proteins, mabs and ADCs

Ten Lessons for the Formulation Development of Monoclonal Antibodies from Multimodal Thermal Unfolding Case Studies

AdvanceBio HIC: a Hydrophobic HPLC Column for Monoclonal Antibody (mab) Variant Analysis

for MA and Beyond John Gabrielson CASSS 2 nd International Symposium on Higher Order Structure of Protein Therapeutics

When proteins are being developed as therapeutics, an important consideration is both the inherent conformational

Development of High Concentration cetuximab Formulations using Ultrafiltration and Precipitation Techniques

Automated Chemical Denaturation as a Tool to Evaluate Protein Stability and Optimize the Formulation of Biologics

Assistant Professor Mohammad A Alsenaidy, MSc, PhD, Saudi Arabia

FORMULATION & LYOPHILIZATION CYCLE DEVELOPMENT OF AN ADC

Protein Stability Analysis Using the Optim Patrick Celie NKI Protein Facility, Amsterdam

Forced Degradation of Protein Therapeutics

Regulatory Perspectives on Higher Order Structure Evaluations for Protein Products. Emily Shacter, Ph.D.

Understanding the Effects of Common Mobile Phase Additives on the Performance of Size Exclusion Chromatography

Modular DSP approaches for complex non-mab molecules

Cryoconcentration effects during freeze/thaw processing of bulk protein, and possible consequences of frozen storage on protein aggregation

Off to the races: rapid buffer exchange, protein quantification and stability screening with Junior, Lunatic and Uncle

MICROCAL PEAQ-DSC BIOMOLECULAR STABILITY ANALYSIS FOR THE REGULATED ENVIRONMENT LABEL-FREE ANALYSIS MICROCALORIMETRY

Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system

Suppl. Table I. Design of mutations within the BIIB4 and BIIB5 scfvs for screening in a thermal challenge assay.

Accelerating the development of optimized therapeutic protein formulations using Differential Scanning Calorimetry

Mass Spectrometry for Characterization of Monoclonal Antibodies: Regulatory Considerations

Formulation Development

Formulation Aspects in Biosimilar Development. Kedar S. Gokhale, PhD. Lupin Ltd. (Biotech)

High Throughput Biophysical Approaches to Preformulation Characterization and Comparability Analysis of Protein Drugs and Macromolecular Vaccines

Size-exclusion chromatography TT30 sample was analyzed using a Tosoh Haas TSK Gel G3000SW XL 7.8 mm 30cm column at 1 ml/min and 280 nm detection.

Quantify protein stability with ΔG

Using sequence analysis and design to mitigate formulation concerns during pre-clinical development

Localized Higher Order Structures of mabs and ADCs Investigated by MS-based Protein Footprinting

GE Healthcare Life Sciences. Development and optimization of protein formulations

Structural Aspects of Immunogenicity: Aggregates

CONSEQUENCES OF SAMPLE AGE ON BIOTHERAPEUTIC HIGHER ORDER STRUCTURE: INSIGHTS FROM NATIVE ION MOBILITY-MASS SPECTROMETRY METHODS

Technical Challenges in the Development of Biosimilars. E. Morrey Atkinson, PhD Interphex May 1, 2012

Biosimilar Profiling Application Note NT-PR-010

Extracting Pure Proteins from Cells

Characterisation of proteins

The Present State and Future Outlook for Characterizing the Higher Order Structure (HOS) of Protein Drugs in the Biopharmaceutical Industry

Stability of Biopharmaceuticals: Past, Present and Future. Paul Varley, Vice President, Biopharmaceutical Development

Challenges in peptide mapping mass spectrometry of biopharmaceuticals

3D Structure of Biologics in a Convenient Immunoassay Format

CBI Toolbox Tour 2015

Physical Methods in Models of Cataract Disease. O. P. Srivastava Department of Vision Science University of Alabama at Birmingham

Fluorescent dyes as tools to detect changes in higher order. protein structures

Analytical similarity: Lessons from the first US biosimilar

9/16/2011. Fluorescent Dye-based Methods to Detect Changes in Higher Order Structures. Protein aggregation

A Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies

Develop A Highly Similar" Biosimilar Compound: Lessons Learnt

Analysis of Protein Biopharmaceuticals

Pharmaceutical Development for ADCs: Not as Simple as ABC

Characterization of biopharmaceutical stability with Differential Scanning Calorimetry: Candidate selection for developability

Expert Consensus on Quality Control and Preclinical Evaluation of Antibody-Drug Conjugates

SUPPLEMENTARY INFORMATION

ALP (alkaline phosphatase) calibrators were analyzed manually in microtiter plates to find the linearity range by following this protocol:

Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance

Assessment of Active Biopharmaceutical Ingredients Prior To and Following Removal of Interfering Excipients

Case Study: A Phase-Driven Approach to the Development and Lifecycle Management of Potency Assays. Spring in New England!!!

Conjugated protein biotherapeutics

Thermo Scientific MAbPac HIC Columns. Novel Hydrophobic Interaction HPLC Columns. Designed for Monoclonal Antibody Analysis

Quantitative Evaluation of the Ability of Ionic Liquids to Offset the Cold- Induced Unfolding of Proteins

Practical Considerations in Developing High Concentration Antibody Formulations

Peptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST

Analysis of NFU-1 metallocofactor binding-site substitutions impacts on iron sulfur cluster coordination and protein structure and function

UV Fluorescence Polarization as a Means to Investigate Protein Conformational and Mass Change

David Volkin. Department of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center

In Vitro Monitoring of the Formation of Pentamers from the Monomer of GST Fused HPV 16 L1

Antibody-Drug Conjugate Characterization and Quality Assurance

Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade

Thermal Analysis. Dr. Lidia Tajber School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin

Antibody-Drug Conjugates The Road to the Current State. Nila Das, Ph.D. American Drug Delivery & Formulation Summit San Diego, CA June 13, 2016

Introduction to Assay Development

Physical Aging and Fragility of Amorphous Sucrose by DSC

Chapter 6. Techniques of Protein and Nucleic Acid Purification

Small-Scale Physicochemical and Biophysical Characterization to Enable Peptide Delivery in Discovery

The Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives

Prometheus NT.48 Product Information

ENZYME CATALYSTS FOR A BIOTECHNOLOGY-BASED CHEMICAL INDUSTRY

R R Innovation Way P/N SECKIT-7830 Newark, DE 19711, USA Tel: Fax: Website: Published in November 2013

Guide. recombinant DNA proteins. for the elaboration of monographs on synthetic peptides and. European Pharmacopoeia

Comparison of ExoSAP-IT and ExoSAP-IT Express reagents to alternative PCR cleanup methods

Changes to a Potency Bioassay for Biotechnology Products: a Regulatory Perspective Kathleen A. Clouse, Ph.D., Director Division of Monoclonal Antibodi

Supplementary Note 1. Enzymatic properties of the purified Syn BVR

Supporting Information

Higher Order Structure: Route to QC testing? Carl Jone, UCB, Belgium CASSS AT in Europe, Brussels, Belgium March 2016

Chromatography column for therapeutic protein analysis

Rapid Kinetics with IR Protein folding examples

Stability of Biological Products

AAPS Short Course: Characterization Methods for Aggregates and Particles in Peptide and Small Protein Formulations

Effect of Liquid Handling QC on Biological Assay Performance. 06 Feb 2012 Artel Tutorial Nathaniel Hentz, PhD

Renaturation Basic Kit for Proteins

Comparability Analysis of Protein Therapeutics by Bottom-Up LC-MS with Stable Isotope-Tagged Reference Standards

Transcription:

Value of DSC in characterization and optimization of protein stability as compared to other thermal stability assays 韩佩韦 Malvern Instruments 2016.02.28

Complex task of characterization and optimization of protein stability Chemical stress (ph, ionic strength, etc.) Physical stress (filtration, temperature, air-liquid interface) Freeze-thaw-induced stress

Challenge: numerous causes of protein instability matched by numerous remedies to be tested empirically Buffering agents Amino acids Osmolytes Sugars and carbohydrates Proteins and polymers Salts Surfactants Ligands... Stabilization might be achieved through : changes in bulk solutions properties specific interaction with protein inhibition of a degradation pathway

Buffer attribute 2 Profiling and optimization of protein stability remains a combination of trial-and-error and rational approaches 3 2 1 70 Understanding of factors (intrinsic 60 and extrinsic) critical to protein stability on the molecular 50 level is needed for implementation of the rational approach 40 to optimization of protein stability. 30 20 0 10 20 30 40 50 Buffer attribute 1 10

Multiple biophysical methods used for characterization of protein stability Mass spectrometry (MS) Circular dichroism (CD) Fourier transform infrared spectroscopy (FTIR) Raman spectroscopy X-ray crystallography Nuclear magnetic resonance (NMR) Near-UV CD SEC HPLC Fluorescence Static and dynamic light scattering (SLS and DLS) Differential scanning calorimetry (DSC) Analytical ultracentrifugation (AUC)

Issues: Stability Indicator: Existing solutions: Thermal stability as generic indicator of protein stability Long-term costly stability studies of multiple samples. Involve lengthy incubation times & many analysis rounds for multiple samples. Protein long-term stability often correlates with thermal stability Assessment and optimization of protein stability through studies of thermal stability

Existing ways to assess thermal stability: Subject protein solution to a temperature up-scan and monitor changes in a property DSC IF DSF UV DLS&SLS CD BIOCHEM. ASSAY Rheology / Potency

What are we actually measuring? Instrumental readout Macroscopic average property 1st principle physical relations assumptions simplification Property, process Molecular level

DSC instrument readout is directly related to the thermal unfolding event Differential Scanning Calorimetry DSC Directly monitors thermal unfolding event by measuring changes in apparent excess heat capacity of protein sample during temperature up-scan Circular Dichroism Spectropolarimetry In a limited set of buffers follows unfolding through changes of CD spectrum sensitive to secondary and tertiary structure of the protein. Light scattering techniques: DLS and DSLS Indirectly monitor thermal unfolding of proteins through changes in protein size and extent of protein aggregation Differential Scanning Fluorescence, DSF Indirectly monitors thermal unfolding of proteins through changes in hydrophobic area or content of beta-sheet structure accessible to environment-sensitive fluorescent dye Fluorimetery, intrinsic fluorescence Indirectly and locally follows thermal unfolding of proteins by monitoring changes in intrinsic fluorescence of tryptophan and tyrosine residues

Differential Scanning Calorimetry, DSC Thermal stability of proteins at different conditions (buffers, excipients, adjuvants, ligands) Temperature is ramped Thermal denaturation of protein is monitored

MicroCal VP-Capillary DSC System m 130 µl cell volume

DSC offers universal thermal stability assay Heat as universal readout directly related to protein unfolding event No optical artifacts, works in turbid solutions Works under controlled conditions in most of buffers Allows to study protein samples as they are Minimum assay development Delivers multiple descriptors of protein stability

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

Protein unfolding monitored in DSC

DSC thermogram provides multiple descriptors of protein thermal stability T m - thermal transition midpoint, multiple T m for multiple domains T onset - onset of unfolding DT 1/2 - width of a peak at half maximum hight DH cal, DH vh calorimetric and van t Hoff enthalpy Assessment of oligomerization and aggregation propensity Percent reversibility of the transition Kinetics of irreversible process DC p for reversible unfolding

Insights on protein stability accessible with DSC Shifts in Tm values ( C): Higher temperature = more stable Lower temperature = less stable Shifts in Tonset values ( C): Higher temperature = more stable Lower temperature = less stable Lowering of DH, area under the curve: decrease in the content of folded protein DH cal /DH vh ratio Measure of the size of the cooperative unit Changes in T 1/2 values (transition width, C): Smaller width = more cooperative unfolding usually associated with a compact structure Larger width less cooperative usually associated with a relaxed, partially unfolded structure Courtesy of Dr. Katherine E. Bowers, FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

C p (kj K -1 mol -1 ) Use Tm to compare native, altered and mutant forms Native Mutant Phosphorylated Complexed Temperature ( C)

Tm as stability indicating parameter. Case study 1. DSC sensitive to changes in stability arising from a common chemical degradation pathway For each of the studied proteins (2 mabs and 2 fusion proteins), the melting temperature (Tm) decreased linearly as a function of oxidation. For one protein, DSC was shown to be a leading indicator of decreased antigen binding suggesting a subtle conformation change may be underway that can be detected using DSC prior to any observable impact on product potency. Arthur, K. K., Dinh, N. and Gabrielson, J. P. (2015), Technical Decision Making with Higher Order Structure Data: Utilization of Differential Scanning Calorimetry to Elucidate Critical Protein Structural Changes Resulting from Oxidation. J. Pharm. Sci., 104: 1548 1554. doi: 10.1002/jps.24313

Different T m at different protein concentrations indicative of protein oligomerization/ aggregation propensity Monomeric or not? T m shifts detect oligomers T m may shift with sample concentration Monomer Tm is concentration independent Monomeric protein Oligomeric protein

Cp (kcal/mole/ o C) Multiple Tms. DSC allows to address protein stability on domain level. Case study 2. Protein engineering guided by DSC. 150 Minor differences in primary sequence can have a big impact on antibody stability Stability of each domain can be assessed The least stable Fab variant expressed poorly and quickly formed high MW aggregates. Most stable antibody construct identified based on Tm of the Fab domain. 100 50 0 T m 2 = 73.3 C T m 1 = 60.4 C T m 3 = 82.0 C 30 40 50 60 70 80 90 Temperature ( o C) Demarest et al, Malvern Application note

Cp (kcal/mole/ o C) Tonset. Shift in onset of thermal unfolding correlates with protein stability and aggregation propensity. Case study 3. Cp (kcal/mole/ o C) 10 5 0 Data: BpaseTBSLa_cp Model: MN2State Chi^2 = 8813.30 T m 1 17.85 ±0.1932 DH1 2.19E3 ±181 DH v 1 1.13E5 ±1.06E4 T m 2 30.40 ±0.6202 DH2 1.41E4 ±2.8E3 DH v 2 8.04E4 ±4.94E3 T m 3 34.43 ±0.0458 DH3 4.01E4 ±2.68E3 DH v 3 1.25E5 ±2.92E3 onset at 12ºC BPase 8.3uM=0.23mg/ml BB293 in 20mM TBS + 200mM L-alanine ph 8.0 Protein X Construct 1 0 10 20 30 40 50 Temperature ( o C) Tm=34.5ºC DSC: 10ºC upward shift of the lowtemperature transition stabilizes Protein X kinetically. 5 4 3 2 1 0-1 -2 onset at 22ºC Protein X Construct 2 Tm=40ºC ca 0.22 mg/ml BPase BB384 in 20 mm TBS, ph 8.0 0.3% DMSO Data: BB384TBS05_cp Model: MN2State Chi^2 = 7482.82 T m 1 23.73 ±0.0840 DH1 877 ±93.6 DH v 1 4E5 ±5.32E4 T m 2 34.30 ±0.1938 DH2 1.14E4 ±932 DH v 2 9.88E4 ±4.06E3 T m 3 40.10 ±0.0854 DH3 2.64E4 ±939 DH v 3 1E5 ±2.15E3 20 30 40 50 60 Temperature ( o C) Construct 1 Construct 2 SEC SEC: Protein X homogeneity and stability to aggregation has dramatically increased

T 1/2 and Tm. Multiple metrics of protein thermal stability make buffer optimization /preformulation funnel more efficient. Case study 4. 12 selected Rank by T m 19 formulations tested Focus with T 1/2 5 focused on Katherine E. Bowers, Malvern Application Note

DH cal. Area under DSC curve is an indicator of the content of folded protein material. DSC can be used to assess quality of recombinant proteins. Case study 5. Malvern Application Note

DH cal /DH vh ratio as indicator of size of cooperative unit for thermal unfolding DH vh = DH cal cooperative unit and molecular weight are the same: largely reversible unfolding of one single domain DH vh < DH cal - cooperative unit is smaller than molecular weight: intermediates DH vh > DH cal cooperative unit is bigger than the molecular weight: oligomers or overestimated concentration of folded protein

Cp (cal/ o C) Ratio of calorimetric to van t Hoff enthalpy DH/DH vh, can be indicative of protein oligomerization state. Case study 7. 400 350 300 250 200 150 100 Data: Data2_cp Model: MN2State Chi^2/DoF = 99.35 T m 69.15 ±0.021 DH 3376 ±17.2 DH v 1.014E54 ±640 mgst2 50 0-50 20 40 60 80 100 Temperature (Deg. C) Ratio of van t Hoff to calorimetric enthalpy 3 indicates that protein unfolds as an oligomer (possibly trimer).

Existing ways to assess thermal stability: Can DSC make a difference? DSC IF DSF UV DLS&SLS CD BIOCHEM. ASSAY Rheology / Potency

How DSC performs against other thermal stability assays? Case study 8. Buffer optimization conducted with DSC, DSF and IF. Thermal stability screening of >500 samples 3 different proteins (2 mabs and one receptor protein 30 different buffer conditions. Thermal unfolding of the protein was followed with DSC, DSF and IF.

Proteostat Tm C Sypro Orange Tm C When it works DSF correlates rather well with DSC (Tm1) Screens at: 0.3 mg/ml 80 75 70 65 60 55 50 45 80 75 70 65 60 55 50 55 60 65 70 75 80 R²= 0.8023 DSF R²= 0.7253 DSF 60 65 70 75 DSC Tm C

Proteostat Tm C Sypro Orange Tm C When it works DSF correlates rather well with DSC (Tm1) Screens at: 0.3 mg/ml 80 75 70 65 60 55 50 45 80 75 70 65 60 55 50 55 60 65 70 75 80 R²= 0.8023 BUT does DSF always work? DSF R²= 0.7253 DSF 60 65 70 75 DSC Tm C

DSF is not truly universal assay DSF is not applicable to all proteins and all buffer compositions. One out of 3 proteins in this study was not amenable to DSF with either of the extrinsic dyes SyproOrange or ENZO. Self-associating excipients corrupted the readout of DSF. Domain resolution was not achieved with DSF

DSF ProteoStat Enzo DSF Sypro Orange MicroCal Cap DSC automated Performance varies a lot between DSC and DSF techniques Technique Protein mab1 mab2 % samples amenable to analysis % samples with domain resolution % samples amenable to auto data analysis 100 100 100 Receptor X 100 one peak 100 mab1 91 28 66 mab2 74 50 30 Receptor X failed mab1 100 0 27 mab2 100 0 0 Receptor X failed

Domain resolution generally only achieved in DSC Domain resolution for all buffers was only achieved with DSC. DSF is less effective when looking at domains and their stabilization. Peak amplitude in DSF is not domain-specific. Direct nature of DSC readout ensures robustness of baseline definition and domain resolution.

Why/when data on thermal stability of individual domains can be of importance Guiding protein engineering work Comparing proteins produced with different expressions systems (glycosylation effect on domain stability) Relating changes in functional activity to stability changes of individual domains Selecting optimal condition during pre/formulation studies Characterization of Higher Order Structure (HOS) Comparability analysis

DSC vs IF in the buffer screen of mab1 sample. IF data can be difficult to interpret IF readout susceptible to optical artefacts like quenching, innerfiltering, aggregation, and light scattering

DSC has non-optical readout. DSC measurements are not affected by sample turbidity or presence of self-associating reagents in the buffers. DSF DSC DSC can be applied to the analysis of samples from long-term and stress-stability studies DSC gives means to assess conformational equivalence/biocomparability of protein batches originating from different processes and sources

DSC readout is directly related to protein concentration and conformational state. DSC thermogram is a fingerprint for assessment of conformational equivalence and Higher Order Structure. Three lots manufactured at different sites DSC verifies no difference in stability and solubility between DP lots Lot 3 Lot 2 Lot 1 Reference Malvern Application Note

Summary DSC is truly universal and generic assay. DSC is the only thermal stability (TS) method with direct readout DSC is information rich (multiple descriptors of thermal unfolding) allowing for rational data interpretation for protein characterization and stability screening DSC thermograms are sample specific, quantitative and reproducible. Allows for similarity analysis. DSC is a well-established tool used to validate other TS assays.

With Differential Scanning Calorimetry you can: Characterize protein stability Characterize domain structures Assess oligomerization state Screen engineered and recombinant proteins for stability and manufacturability Determine optimum solution conditions for protein purification and formulation development Assess biocomparability and biosimilarity Study/screen protein-ligand interaction

Thank you for your attention! Questions?